• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 15
  • 2
  • 1

PRICE

2
2
17
18

PUBLISHED

0
4
14
18

PRODUCT TYPE

15
3

Search "Neotropix, Inc.-Detailed Product Pipeline" returned 18 results.

PRODUCT TITLE
Neotropix, Inc. - Product Pipeline Review - 2012 Neotropix, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Neotropix, Inc. - Product Pipeline Review - 2012

Neotropix, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neotropix, Inc. - Product Pipeline Review - 2012” provides data on the Neotropix, Inc.’s research...

September 2012
FROM
Neotropix, Inc. - Product Pipeline Review - Q4 2010 Neotropix, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Neotropix, Inc. - Product Pipeline Review - Q4 2010

Neotropix, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Neotropix, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Neotropix, Inc. - Product Pipeline Review - Q4 2010

Neotropix, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Neotropix, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Rhabdomyosarcoma - Pipeline Review, H2 2014

Rhabdomyosarcoma - Pipeline Review, H2 2014 Summary This, ‘Rhabdomyosarcoma - Pipeline Review, H2 2014’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline. This report provides...

December 2014
FROM
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 - Product Thumbnail Image

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Summary This, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014’, provides an overview of the...

November 2014
FROM

Retinoblastoma - Pipeline Review, H2 2014

Retinoblastoma - Pipeline Review, H2 2014 Summary This, ‘Retinoblastoma - Pipeline Review, H2 2014’, provides an overview of the Retinoblastoma’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Retinoblastoma - Pipeline Review, H1 2014

Retinoblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H1 2014’, provides an overview of the Retinoblastoma’s therapeutic pipeline. This report...

May 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H1 2014

Small-Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic...

February 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H2 2014

Small-Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Small-Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

July 2014
FROM
Lung Cancer - Pipeline Review, H2 2012 Lung Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Lung Cancer - Pipeline Review, H2 2012

Lung Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Lung Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2012
FROM

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

April 2014
FROM

Rhabdomyosarcoma - Pipeline Review, H1 2014

Rhabdomyosarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2014’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline. This...

June 2014
FROM

Neuroblastoma - Pipeline Review, H1 2014

Neuroblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report...

February 2014
FROM

Neuroblastoma - Pipeline Review, H2 2014

Neuroblastoma - Pipeline Review, H2 2014 Summary This, ‘Neuroblastoma - Pipeline Review, H2 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H1 2014

Non-Small Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Non-Small Cell Lung Cancer’s...

March 2014
FROM

Squamous Cell Carcinoma - Pipeline Review, H2 2014

Squamous Cell Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Squamous Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Squamous Cell Carcinoma’s therapeutic pipeline. This...

October 2014
FROM

Squamous Cell Carcinoma - Pipeline Review, H1 2014

Squamous Cell Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Squamous Cell Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Squamous Cell Carcinoma’s therapeutic...

April 2014
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.